Population Pharmacokinetics of the Antituberculosis Agent Pretomanid

por Salinger, David H., Subramoney, Vishak, Everitt, Daniel, Nedelman, Jerry R.
Publicado 2019

Daily Dosing for Bedaquiline in Patients with Tuberculosis

por Salinger, David H., Nedelman, Jerry R., Mendel, Carl, Spigelman, Melvin, Hermann, David J.
Publicado 2019

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis

por Li, Hanbin, Salinger, David H., Everitt, Daniel, Li, Mengchun, Del Parigi, Angelo, Mendel, Carl, Nedelman, Jerry R.
Publicado 2019

An Exposure-Response Perspective on the Clinical Dose of Pretomanid

por Nedelman, Jerry R., Salinger, David H., Subramoney, Vishak, Woolson, Rob, Wade, Karen, Li, Mengchun, Everitt, Daniel, Mendel, Carl M., Spigelman, Mel
Publicado 2020

Prediction of clinical pharmacokinetics of AMG 181, a human anti-α(4)β(7) monoclonal antibody for treating inflammatory bowel diseases

por Li, Hong, Köck, Kathleen, Wisler, John A, Rees, William A, Prince, Peter J, Reynhardt, Kai O, Hsu, Hailing, Yu, Zhigang, Borie, Dominic C, Salinger, David H, Pan, Wei-Jian
Publicado 2015